Protective efficacy of inactivated reverse genetics based equine influenza vaccine candidate adjuvanted with Montanide<sup>TM</sup> Pet Gel in murine model-Reference-Cited by-同舟云学术

Protective efficacy of inactivated reverse genetics based equine influenza vaccine candidate adjuvanted with Montanide^TM Pet Gel in murine model

Published:2019 Issue:12 Volume:81 Page:1753-1762
ISSN:0916-7250
Container-title:Journal of Veterinary Medical Science
language:en
Short-container-title:The Journal of Veterinary Medical Science

Author:

MATHEW Manu Kurian¹,VIRMANI Nitin¹,BERA Bidhan Chandra¹,ANAND Taruna¹,KUMAR Ramesh²,BALENA Venkataramireddy¹,SANSANWAL Rekha¹,PAVULRAJ Selvaraj¹,SUNDARAM Karthik¹,VIRMANI Meenakshi²,TRIPATHI Bhupendra Nath¹

Affiliation:

1. ICAR-National Research Centre on Equines, Sirsa Road, Hisar-125 001, Haryana, India

2. Lala Lajpat Rai University of Veterinary & Animal Sciences, Hisar-125004 Haryana, India

Publisher

Japanese Society of Veterinary Science

Subject

General Veterinary

Link

https://www.jstage.jst.go.jp/article/jvms/81/12/81_19-0399/_pdf

Reference32 articles.

1. 1. Benne, C. A., Harmsen, M., van der Graaff, W., Verheul, A. F., Snippe, H. and Kraaijeveld, C. A. 1997. Influenza virus neutralizing antibodies and IgG isotype profiles after immunization of mice with influenza A subunit vaccine using various adjuvants. Vaccine 15: 1039–1044.

2. 2. Bhardwaj, N., Seder, R. A., Reddy, A. and Feldman, M. V. 1996. IL-12 in conjunction with dendritic cells enhances antiviral CD8+ CTL responses in vitro. J. Clin. Invest. 98: 715–722.

3. 3. Bhatia, S., Khandia, R., Sood, R., Bhat, S., Siddiqui, A., Jahagirdhar, G., Mishra, S., Mishra, A., Pateriya, A. K. and Kulkarni, D. D. 2016. Reverse genetics based rgH5N2 vaccine provides protection against high dose challenge of H5N1 avian influenza virus in chicken. Microb. Pathog. 97: 172–177.

4. 4. Cauchard, S., Bertrand, F., Barrier-Battut, I., Jacquet, S., Laurentie, M., Barbey, C., Laugier, C., Deville, S. and Cauchard, J. 2014. Assessment of the safety and immunogenicity of Rhodococcus equi-secreted proteins combined with either a liquid nanoparticle (IMS 3012) or a polymeric (PET GEL A) water-based adjuvant in adult horses and foals—identification of promising new candidate antigens. Vet. Immunol. Immunopathol. 157: 164–174.

5. 5. de Wit, E., Munster, V. J., Spronken, M. I., Bestebroer, T. M., Baas, C., Beyer, W. E., Rimmelzwaan, G. F., Osterhaus, A. D. and Fouchier, R. A. 2005. Protection of mice against lethal infection with highly pathogenic H7N7 influenza A virus by using a recombinant low-pathogenicity vaccine strain. J. Virol. 79: 12401–12407.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of immunogenicity and protective efficacy of bacteriophage conjugated haemagglutinin based subunit vaccine against equine influenza virus in a murine model;Veterinary Research Communications;2024-03-26

2. Immunogenicity and safety studies of an inactivated vaccine against Rift Valley fever;Acta Tropica;2022-08

3. Screening immune adjuvants for an inactivated vaccine against Erysipelothrix rhusiopathiae;Frontiers in Veterinary Science;2022-07-26

4. Immunogenicity of Calvenza-03 EIV/EHV® Vaccine in Horses: Comparative In Vivo Study;Vaccines;2021-02-17

5. Self-assembled peptide nanorod vaccine confers protection against influenza A virus;Biomaterials;2021-02